Strong Foundation: on the up after IPO
This article was originally published in Clinica
Executive Summary
Molecular diagnostics firm Foundation Medicine is riding high after an initial public offering (IPO) brought in more than it had anticipated. The firm sold 5.9 million shares at $18 each, giving it a grand total of $106m – above the hoped-for target of 5 million shares at $14-16 apiece (www.clinica.co.uk, 16 September 2013).